Clinical trial
CBT With Disulfiram and Contingency Management
NCT00350870 · Yale University, Other · Completed
Key facts
| NCT number | NCT00350870 |
|---|---|
| Title | CBT With Disulfiram and Contingency Management |
| Official title | Maximizing the Efficacy of Cognitive Behavioral Therapy With Medication and Contingency Management |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cocaine Abuse |
| Intervention type | Behavioral, Drug |
| Interventions | disulfiram, Placebo, Placebo plus Contingency Management, Disulfiram plus Contingency Management |
| Enrollment | 181 |
| Start date | Apr 1, 2005 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Jul 11, 2006 |
| Last update posted | Dec 3, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: